Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy

ABSTRACT: A comparison of prophylactic treatment with reactive treatment for skin toxicity observed in patients with metastatic colorectal cancer (mCRC) who are receiving second-line irinotecan-based chemotherapy concomitantly with panitumumab.

DISEASE(S): Metastatic Colorectal Cancer,Exanthema,Colon Cancer,Skin Toxicities,Colorectal Cancer,Colorectal Neoplasms,Skin Rash,Colonic Neoplasms

PROVIDER: 2029392 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR